- Price
- $11.35
- Day
- +5.68%
- Mkt Cap
- $112.97M
- 52W Range
- $5.20 – $55.89
- Volume
- 132.4K
- Beta
- 2.11
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
Enlivex Therapeutics (NASDAQ: ENLV - Get Free Report) and Korro Bio (NASDAQ: KRRO - Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, risk, institutional ownership, earnings, valuation and profitability. Institutional and Insider Ownership 1.0% of Enlivex
Read full article